Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Even with all the Turley promotion. PTSC is still not clear to investors. Read!

Even with all the Turley promotion. PTSC is still not clear to investors. Read!

posted on Oct 30, 2007 08:04PM
Even with all the Turley promotion. PTSC is still not clear to investors.

I got this email today. Also included is the up to date follow ups.


The Latest from The Microcap Speculator
Patriot Scientific (PTSC) continues to ink licenses, but will it return to profitability?

Posted: 29 Oct 2007 04:25 PM CDT

Patriot Scientific (PTSC.OB) traders have had a wild ride for the past two years. Since January 1996, the stock shot up from 8 cents to over $2. Now, as the weekly chart below shows, the stock is trying to bottom around $.40.

Whether the bottom holds will likely be dependent on the company’s return to profitability. For a few quarters, Patriot Scientific announced not only substantial profits, but numerous dividends, as its licensing joint venture secured key deals with PC, semiconductor and electronic manufacturers to license the Moore Patent Portfolio, of which the company is part-owner. As the pace and (by most estimates) size of the licensing deals began to subside, operating metrics also deteriorated. Last quarter, Patriot Scientific lost $1.96 million on licensing proceeds to the joint venture of $1.5 million.

Today, the company announced that it had reached a deal with Philips Electronics. “We welcome the expansion of our program with Philips, a proven worldwide leader in medical equipment and consumer electronics. This agreement further validates the strength and broad scope of the MMP Portfolio,” said Andre-Pascal Chauvin, vice president of licensing for Alliacense, Patriot Scientific’s licensing partner. More importantly, the company suggested that further deals could be in the pipeline: “It’s pretty common to see the pace of deals pick up as a trial approaches,” said Mike Davis, senior vice president, licensing. “A number of major businesses that have been following the case closely needed a little time to evaluate the recent Markman ruling, and are now moving to capture licenses at current prices and avoid significantly higher royalty rates following trial.”

Bottom line: This is certainly good news for Patriot, but the size of the Philips deal has not been disclosed and I for one will remain skeptical until I see the company transform its dealflow into a significant, lasting revenue stream. With a market cap. of $164.33M (per Yahoo!), lofty expectations are still baked into the share price. Unless PTSC starts delivering profits soon, shareholders are likely to see more disappointment.

DISCLOSURE: No position.

I RESPONDED AND RECEIVED THIS. I AGAIN RESPONDED.

PTSC note ; Each license is worth 5 million dollars plus repeat revenue from maintenance agreements.
Every sign on licensure equals 5 million big fat ones in the PTSC bank.

signed TechKim

NEXT MESSAGE!
What is your support for that figure? thx
signed MicrocapSpeculator

I RESPONDED WITH THIS!
Each deal is estimated about $5,000,000 according to the slide show of the Arch-Micro Cap conference .

http://origin.vcall.com/CustomEvent/conferences/arch_investment/090607/webcast.htm

signed TechKim
--------------------------------------------------------------

Now before some of you start going bannanas. The microcapspeculator does a fine job overall for a news letter.
Now turn the real news on and outward.

The constant PACER postings without some type of small interpretation do little to no good for new investors. Most investors see the lawsuit as a company to stay away from.

I trust this investor relations firm PTSC does more than wait around for retail investors to telephone them with inquiries.

Now lets see what the microcapinvestor responds with!
Remember he is seeking knowledge and clearification.
Share
New Message
Please login to post a reply